#USA #Torrance #Phenomenex #Endrix #Long Life

Phenomenex Launches Revolutionary Endrix Long Life Columns

In a significant advancement for the field of liquid chromatography, Phenomenex Inc., a subsidiary of Danaher Corporation and a global leader in separation science technology, has introduced the Endrix Long Life LC columns. This innovative solution promises to redefine the standards of column durability and method reliability within analytical laboratories.

Addressing Laboratory Challenges

As laboratories increasingly face the pressures of delivering high-quality data amid complex sample matrices and tighter deadlines, the Endrix Long Life LC aims to address these challenges head-on. Eric Lavold, Vice President of Product Management and Strategy at Phenomenex, emphasized that the column was developed specifically to meet the demands for extended column lifetimes while maintaining dependable performance throughout rigorous testing conditions.

Designed to withstand intricate sample matrices and harsh method conditions, the Endrix Long Life LC column helps laboratories transition smoothly from method development to reproducible results with minimal downtime. This is particularly crucial for laboratories that rely on continuous, uninterrupted operation to achieve consistent and accurate outcomes.

Robust Design for Longevity

The Endrix Long Life LC column features a robust construction that safeguards it against common failure mechanisms, including peak distortion, pressure spikes due to accumulation, and performance variability. By prioritizing longevity and consistency from the outset, Phenomenex enables laboratories to maintain the integrity of their methods over extended analytical campaigns. This makes the columns an ideal choice for pharmaceutical, clinical, forensic, toxicological, environmental, and food analysis laboratories where method reliability is paramount.

Official Launch and Applications at ASMS 2026

The official introduction of the Endrix Long Life LC column will take place at the upcoming 73rd ASMS Conference on Mass Spectrometry and Allied Topics (ASMS 2026). Attendees will have the opportunity to explore application data and discuss best practices for utilizing the Endrix technology at Booth 802, where Phenomenex specialists will be available to provide insights and answer questions.

About Phenomenex

Phenomenex is a technology-driven company dedicated to developing innovative analytical chemistry solutions that tackle the separation and purification challenges faced by researchers in academic, pharmaceutical, biotechnological, environmental, clinical research, governmental, and industrial laboratories. Phenomenex’s chromatography solutions not only accelerate scientific advancement but also empower researchers to enhance human health and wellbeing through improved drug discovery, pharmaceutical development, food safety, and environmental analysis.

Renowned Parent Company: Danaher

As part of Danaher, a leading global life sciences and diagnostics innovator, Phenomenex benefits from a comprehensive ecosystem of industry-leading companies committed to solving the most complex scientific and clinical challenges faced by their clients. Danaher’s Business System drives innovation and operational excellence, allowing for faster and more precise diagnostics that ultimately help deliver transformative therapies to patients promptly.

Together, with roughly 60,000 employees dedicated to improving global health and well-being, Phenomenex and Danaher uphold a commitment to making a lasting impact through the power of science and technology.

For further information, visit Phenomenex and follow their blog at Science Unfiltered. Connect with them on LinkedIn, Twitter, Facebook, Instagram, and YouTube for the latest updates.